ASTM International’s medical and surgical devices committee (F04) has approved a new standard designed to provide details and considerations for planning and conducting a seal zone leakage assessment for stent grafts. This new standard, anticipated to be published as F3849, will be utilized by commercial and new product development quality engineers within medical device companies. The standard’s purpose is to evaluate stent graft devices. It will also be used by contract testing companies that fulfill ISO testing requirements for medical device submissions. The standard aims to drive alignment and understanding between regulatory bodies and device manufacturers regarding the accepted practices for fulfilling the seal zone leakage test for stent graft devices. “Lucas Chavez-Pardini, Member, ASTM International” stated that this effort directly relates to the United Nations Sustainable Development Goal #3 on good health and well-being. Users of the new standard are encouraged to contact the F04 committee with any feedback that could be helpful for future editions. ASTM welcomes participation in the development of its standards. Individuals are encouraged to become a member at www.astm.org/JOIN.